IRIS
CAPONE, EMILY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.013
EU - Europa 787
AS - Asia 501
SA - Sud America 92
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.008
SG - Singapore 278
IT - Italia 273
IE - Irlanda 157
CN - Cina 102
SE - Svezia 87
BR - Brasile 82
DE - Germania 58
FR - Francia 46
TR - Turchia 38
UA - Ucraina 33
FI - Finlandia 30
IN - India 30
RU - Federazione Russa 27
GB - Regno Unito 25
VN - Vietnam 22
BE - Belgio 13
NL - Olanda 9
AT - Austria 8
HK - Hong Kong 7
AE - Emirati Arabi Uniti 6
GR - Grecia 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
ZA - Sudafrica 4
CA - Canada 3
JP - Giappone 3
AR - Argentina 2
EG - Egitto 2
IQ - Iraq 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
TW - Taiwan 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.403
Salva come PNG Salva come JPEG
Città #
Chandler 207
Singapore 172
Dublin 155
The Dalles 82
Jacksonville 71
Princeton 53
Pescara 52
Santa Clara 47
Ann Arbor 43
Chieti 41
Ashburn 37
Boardman 29
Altamura 27
Beijing 23
Dong Ket 22
Dearborn 20
Los Angeles 19
Izmir 18
Munich 18
Nanjing 18
Wilmington 18
New York 16
Brussels 13
Lappeenranta 11
Nuremberg 11
Milan 10
Pune 9
Southend 8
Cambridge 7
Falls Church 7
Hebei 7
Helsinki 7
Hong Kong 7
Frankfurt am Main 6
Turku 6
Dubai 5
Finale Ligure 5
Nanchang 5
Norwalk 5
Salvador 5
Washington 5
Castignano 4
Collecorvino 4
London 4
L’Aquila 4
Putignano 4
Redwood City 4
Rio de Janeiro 4
Seattle 4
Shijiazhuang 4
Woodbridge 4
Zhengzhou 4
Brno 3
Brooklyn 3
Istanbul 3
L'aquila 3
Mcallen 3
Moscow 3
Perugia 3
Presidente Prudente 3
Silvi 3
Stockholm 3
Tappahannock 3
Andover 2
Atlanta 2
Camerino 2
Campinas 2
Cattolica 2
Changsha 2
Chicago 2
Chongqing 2
Civitanova Marche 2
Cosenza 2
Dallas 2
Dübendorf 2
Düsseldorf 2
Espoo 2
Fairfield 2
Goiânia 2
Guarulhos 2
Hefei 2
Ipatinga 2
Jinan 2
Johannesburg 2
Kunming 2
Lauterbourg 2
Leinì 2
Manassas 2
Messina 2
Montesilvano Marina 2
Mumbai 2
Newark 2
Ningbo 2
Parabiago 2
Phoenix 2
Porto Alegre 2
Rome 2
Romola 2
San Francisco 2
San Salvo 2
Totale 1.478
Salva come PNG Salva come JPEG
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 138
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 133
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 128
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 108
ABCC3 is a novel target for the treatment of pancreatic cancer 105
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 104
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 103
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 101
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 99
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 90
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 84
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 82
Normal breathing releases SARS-CoV-2 into the air 81
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 77
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 77
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 71
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 71
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 70
Antibody-drug conjugates: The new frontier of chemotherapy 70
HER-3: Hub for escape mechanisms 68
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 66
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 65
Endosialin-binding antibody 60
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 55
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 55
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 55
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 52
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 51
MYC regulates metabolism through vesicular transfer of glycolytic kinases 43
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 40
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 36
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 30
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 29
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 28
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 22
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 21
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 10
Totale 2.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.753
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/2021177 20 3 24 4 10 30 8 4 9 25 8 32
2021/2022175 6 3 4 25 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/2025954 34 180 162 53 21 39 42 48 128 69 152 26
Totale 2.578